Novel CCR3-targeted cyclic peptides as potential therapeutic agents for age-related macular degeneration via inhibiting angiogenesis and reducing retinal photoreceptor damage

unknow

★ 5.0 · 19 reads

Sign in to save this
Request Code
ZLIB.IO18501824
Published
2022
Pages
1
Language
Unknown